New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 5, 2013
09:12 EDTAFDA approves two Dako assays
Dako, an Agilent Technologies company, announced it has received approval from the FDA for the addition of Kadcyla in the labeling of two Dako companion diagnostic assays. Kadcyla is Genentech's new medicine for patients with HER2-positive metastatic breast cancer who have received prior treatment with Genentech's cancer medicine Herceptin and a taxane chemotherapy. The two assays are Dako's HercepTest and HER2 IQFISH pharmDx.
News For A From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 23, 2015
11:02 EDTAAgilent announces strategic collaboration with National University of Singapore
Subscribe for More Information
April 22, 2015
16:15 EDTAAgilent announces resolution to FDA warning letter for Dako Denmark
Subscribe for More Information
April 21, 2015
08:51 EDTAJPMorgan life sciences analyst holds an analyst/industry conference call
Subscribe for More Information
April 19, 2015
14:47 EDTAMerck submits supplemental biologics license for Keytruda in lung cancer
Subscribe for More Information
April 13, 2015
16:18 EDTAeBay announces executive appointments ahead of PayPal separation
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use